The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. In this first webinar of the series, Professor Geoff Hill from the Fred Hutchinson Cancer Research Centre in Seattle will review the pathogenesis of graft versus host disease and discuss approaches to its prevention and treatment. Professor David Gottlieb will review the evidence for use of anti-T cell antibodies for prophylaxis of acute and chronic graft versus host disease in allogeneic stem cell transplant 

Speakers:

Professor Geoff Hill - Fred Hutchinson Cancer Research Centre

Professor David Gottlieb - Westmead Hospital and University of Sydney

When: 6 August 2020 8am AEST

To register: download flyer 

For more information: bloodcelltherapy.org.au